Rockwell Medical (RMTI) Gross Margin (2010 - 2026)

Rockwell Medical has reported Gross Margin for 17 years, with the latest figure at 16.71% in Q1 2026.

• For the quarter ending Q1 2026, Gross Margin rose 63.0% year-over-year to 16.71%; the trailing twelve-month figure through Mar 2026 stood at 17.07% (down 80.0% YoY), and the FY2025 full-year result was 16.89%, down 34.0% from the prior year.
• Gross Margin for Q1 2026 stood at 16.71%, down from 21.14% in the prior quarter.
• The five-year high for Gross Margin was 22.03% in Q3 2024, with the low at 4.87% in Q1 2022.
• Historically, Gross Margin has averaged 12.56% across 5 years, with a median of 13.51% in 2024.
• Annual changes were most pronounced in 2022 — Gross Margin jumped 2667 bps — and 2025, when it plunged 777 bps.
• Rockwell Medical's Gross Margin stood at 12.12% in 2022, then grew by 7 bps to 12.99% in 2023, then advanced by 13 bps to 14.72% in 2024, then jumped by 44 bps to 21.14% in 2025, then slipped by 21 bps to 16.71% in 2026.
• The last three Gross Margin figures came in at 16.71% (Q1 2026), 21.14% (Q4 2025), and 14.27% (Q3 2025), per Business Quant data.